Youtubeยท2025-09-23 14:00Company Overview - Can View's stock is rallying approximately 6.5% following the company's pushback against claims linking Tylenol to autism made by the Trump administration [1][2] - The parent company asserts that independent science shows no causal link between acetaminophen and autism, countering the FDA's recent commentary on the potential association [2][3] FDA Commentary - The FDA acknowledged studies suggesting a possible association between acetaminophen use during pregnancy and neurological conditions but emphasized that a causal relationship has not been established [3][6] - Medical professionals have also rejected the claims made regarding Tylenol and autism, supporting the company's position [3][6] Market Impact - Tylenol's stock had previously slumped to its lowest level of the year, but analysts suggest limited judicial risk following the announcement, although public opinion may impact Tylenol consumption [4][5] - Ken View's stock has decreased by approximately 16.5% over the past month, indicating market volatility surrounding the brand [5] Boeing Orders - Boeing's shares increased by 1.5% due to an $8 billion deal with Uzbekistan Airways for 14 Dreamliners, marking the airline's largest order ever [7][9] - This order is expected to support nearly 35,000 jobs in the US and is part of Uzbekistan's plan to expand its international routes [9] AutoZone Performance - AutoZone reported its fifth consecutive earnings miss, with EPS at $48.71, below the expected $50, and revenue just shy of $6.4 billion against a $6.25 billion expectation [10][11] - Despite the misses, AutoZone's stock is up over 20% year-to-date, indicating resilience in the face of tariff impacts and rising costs [11][12] - The company plans to aggressively open new stores in the upcoming year, although it did not provide a 2026 outlook [13]